Literature DB >> 18429653

Cost-effectiveness analysis: developing nations left behind.

Mendel E Singer.   

Abstract

Mesh：

Year:  2008        PMID： 18429653     DOI： 10.2165/00019053-200826050-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

Review 1.  Cost-effectiveness analysis in radiology.

Authors:  M E Singer; K E Applegate
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

2.  Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

Authors:  Sue J Goldie; Yazdan Yazdanpanah; Elena Losina; Milton C Weinstein; Xavier Anglaret; Rochelle P Walensky; Heather E Hsu; April Kimmel; Charles Holmes; Jonathan E Kaplan; Kenneth A Freedberg
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

3.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.

Authors:  Christopher J L Murray; Jeremy A Lauer; Raymond C W Hutubessy; Louis Niessen; Niels Tomijima; Anthony Rodgers; Carlene M M Lawes; David B Evans
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

4.  Foundations of cost-effectiveness analysis for health and medical practices.

Authors:  M C Weinstein; W B Stason
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245
  4 in total
  9 in total

Review 1.  Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Authors:  Sripen Tantivess; Yot Teerawattananon; Anne Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Developing nations special issue.

Authors:  Mendel E Singer
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 3.  Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.

Authors:  Federico Augustovski; Cynthia Iglesias; Andrea Manca; Michael Drummond; Adolfo Rubinstein; Sebastián García Martí
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Pharmacoeconomic education in Egyptian schools of pharmacy.

Authors:  Ahmed M Soliman; Mustafa Hussein; Abdulla M Abdulhalim
Journal:  Am J Pharm Educ       Date:  2013-04-12       Impact factor: 2.047

5.  Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn?

Authors:  Baudouin Standaert; Olivier Ethgen; Rachel Emerson; Maarten Postma; Josephine Mauskopf
Journal:  Adv Ther       Date:  2014-10-21       Impact factor: 3.845

Review 6.  Pharmacoeconomic education for pharmacy students in bosnia and herzegovina.

Authors:  Tarik Catić; Selma Skrbo
Journal:  Mater Sociomed       Date:  2013-11-24

7.  Key actors' perspectives on cost-effectiveness analysis in Uganda: a cross-sectional survey.

Authors:  Jackson S Musuuza; Mendel E Singer; Anna M Mandalakas; Achilles Katamba
Journal:  BMC Health Serv Res       Date:  2014-11-04       Impact factor: 2.655

8.  Cost-Effectiveness and Resource Allocation (CERA) - directions for the future.

Authors:  Rob Baltussen; Arnab Acharya; Kathryn Antioch; Dan Chisholm; Richard Grieve; Joses Kirigia; Tessa Tan Torres-Edejer; Damien Walker; David Evans
Journal:  Cost Eff Resour Alloc       Date:  2009-07-23

9.  Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE.

Authors:  Sripen Tantivess; Kalipso Chalkidou; Nattha Tritasavit; Yot Teerawattananon
Journal:  F1000Res       Date:  2017-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.